title: CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
abstract: To date cellular immune responses against parvovirus B19 (B19) have not been studied extensively. The aim of this study was to examine the T-cell response against the VP1-unique region as the immunodominant part of the viral structural protein VP1 in individuals with different courses of B19 infection. Therefore, a group of 13 parvovirus-positive probands was separated into subgroups characterized for recent or acute, past or persistent infection by means of the presence of specific immunoglobulin (Ig)M and IgG isotypes and of viral DNA in blood and tissue. Transiently transfected B-cells expressing VP1-unique region were used in ELISpot assays to investigate T-cell responses directed against the VP1-unique region in peripheral blood mononuclear cells (PBMC) of individual donors. Significant numbers of interferon-gamma (IFN-gamma) secreting lymphocytes were detectable in PBMC of all individuals with recent, acute or persistent B19 infection, but not in PBMC of donors with past B19 infection and seronegative individuals. A more detailed analysis of IFN-gamma producing cells by intracellular cytokine staining by flow cytometry revealed, that CD4(+) T cells but not CD8(+) cytotoxic lymphocytes (CTL) were the major subpopulation of IFN-gamma producing cells. These data strongly suggest the need of virus protein production for the maintenance of VP1-unique region-specific CD4(+) T-helper cell responses in B19-infected individuals.
authors.affiliation: Institute of Medical Microbiology and Hygiene, University of Regensburg, 93053 Regensburg, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Lindner
authors.forename: S
authors.initials: S
authors.lastname: Barabas
authors.forename: K
authors.initials: K
authors.lastname: Saar
authors.forename: D
authors.initials: D
authors.lastname: Altmann
authors.forename: A
authors.initials: A
authors.lastname: Pfister
authors.forename: M
authors.initials: M
authors.lastname: Fleck
authors.forename: L
authors.initials: L
authors.lastname: Deml
authors.forename: S
authors.initials: S
authors.lastname: Modrow
mesh_terms: D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D015153:Blotting, Western; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D036022:Capsid Proteins / Q000276:immunology*; D016022:Case-Control Studies; D004279:DNA, Viral / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D008213:Lymphocyte Activation; D010322:Parvoviridae Infections / Q000097:blood / Q000276:immunology* / Q000821:virology; D016732:Parvovirus B19, Human / Q000235:genetics / Q000276:immunology*; D016133:Polymerase Chain Reaction
chemical_list: D000914:Antibodies, Viral; D036022:Capsid Proteins; D004279:DNA, Viral; C095547:capsid protein VP1, parvovirus B19; D007371:Interferon-gamma